Voluntary Delisting
Filed with ASX · · 8 pages · English
Summary by 6ix AI
Tissue Repair Limited has formally applied for removal from the ASX official list, citing reasons such as limited liquidity and high administrative costs. The company plans to seek shareholder approval for the delisting at a general meeting, with arrangements for shareholders to realize value through mechanisms like an off-market share buy-back. If delisted, shares will no longer be traded on ASX, and shareholders will need to engage in private transactions to sell their shares. The filing outlines the timetable for the delisting process and the potential consequences for shareholders.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/voluntary-delisting
Earlier from Tissue Repair
- Appendix 4D and Half Year Report to 31 December 2025
- Quarterly Activities/Appendix 4C Cash Flow Report
- Response to ASX Price Query
- Pause in Trading
- Appendix 4E and Annual Report 30 June 2025
Later from Tissue Repair
All Tissue Repair news releasesFollow Tissue Repair into a list and get an email when it puts out news.
Follow Tissue Repair